ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

In Brief: Top Frederick Job Draws 90 Applicants, With List Now Down to four; New Members Named To NCAB

June 21, 1974